1. Home
  2. Analysis
  3. Famotidine
  4. Oesophageal-dilatation

Famotidine and Oesophageal dilatation - a phase IV clinical study of FDA data

Summary:

Oesophageal dilatation is reported as a side effect among people who take Famotidine (famotidine), especially for people who are male, 60+ old, also take Pantoprazole, and have Neoplasm malignant.

The phase IV clinical study analyzes which people have Oesophageal dilatation when taking Famotidine. It is created by eHealthMe based on reports of 81,914 people who have side effects when taking Famotidine from the FDA, and is updated regularly.

What is Famotidine?

Famotidine has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 83,421 Famotidine users. Check the latest studies of Famotidine.

What is Oesophageal dilatation?

Oesophageal dilatation (enlarged oesophagus) is found to be associated with 133 drugs and 214 conditions by eHealthMe. Check the latest studies of Oesophageal dilatation.

On Jul, 07, 2026

81,914 people reported to have side effects when taking Famotidine.
Among them, 14 people (0.02%) have Oesophageal dilatation.

Could Famotidine cause Oesophageal dilatation?

Among these 14 people:

What is the gender of people who have Oesophageal dilatation when taking Famotidine? *

  • female: 21.43 %
  • male: 78.57 %

What is the age of people who have Oesophageal dilatation when taking Famotidine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 42.86 %
  • 60+: 57.14 %

What are other drugs people take besides Famotidine? *

  1. Pantoprazole: 9 people, 64.29%
  2. Eliquis: 8 people, 57.14%
  3. Zometa: 6 people, 42.86%
  4. Prochlorperazine: 6 people, 42.86%
  5. Levofloxacin: 6 people, 42.86%
  6. Zolpidem: 6 people, 42.86%
  7. Revlimid: 6 people, 42.86%
  8. Lisinopril: 6 people, 42.86%
  9. Cefuroxime: 6 people, 42.86%
  10. Lorazepam: 6 people, 42.86%

What are other side effects people have besides Oesophageal dilatation? *

  1. Pneumonia: 9 people, 64.29%
  2. Pulmonary Embolism (blockage of the main artery of the lung): 9 people, 64.29%
  3. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 9 people, 64.29%
  4. Weight Increased: 7 people, 50.00%
  5. Cough: 7 people, 50.00%
  6. Interstitial Lung Disease: 7 people, 50.00%
  7. Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 6 people, 42.86%
  8. Hypophagia (reduced food intake): 6 people, 42.86%
  9. Dyspnea (difficult or laboured breathing): 6 people, 42.86%
  10. Herpes Zoster: 6 people, 42.86%

What are the existing conditions these people have? *

  1. Neoplasm Malignant (cancer tumour): 6 people, 42.86%
  2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 21.43%
  3. Asthma: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Famotidine and have Oesophageal dilatation?

- Check whether Oesophageal dilatation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Famotidine:

Oesophageal dilatation treatments and more:

How severe was Oesophageal dilatation and when was it recovered:

Expand to all the drugs that have ingredients of famotidine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Famotidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oesophageal dilatation:

Browse all the conditions that are associated with Oesophageal dilatation:

How the study uses the data?

The study uses data from the FDA. It is based on famotidine (the active ingredients of Famotidine) and Famotidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.